Pig Kidney Recipient Reaches One-Year Milestone
A 58-year-old New Hampshire woman has lived one year with a genetically modified pig kidney without serious complications.
Updated on Nov. 22, 2026 in Biotech

Molly Falco, a 58-year-old New Hampshire woman, has lived with a kidney from a genetically modified pig for one year without serious complications. The pig kidney has cleared toxins, made urine and balanced fluids and minerals, and her case is the longest known for a patient with such an organ.
Why it matters
Roughly 90,000 Americans are on the waiting list for a kidney transplant, and fewer than 26,000 transplants were performed last year. Researchers say genetically modified animals could eventually provide a large supply of kidneys, though the use of pig organs remains experimental.
The report is a single-patient outcome, and it covers one year of function for one 58-year-old patient. Over half a million Americans rely on dialysis, while about 12 people die each day waiting for a kidney transplant, and the durability of the pig kidney beyond this period remains unknown.
The players
Mass General Brigham Transplant Center
A transplant center affiliated with Mass General Brigham, a Boston-based health system with a major kidney transplantation research program.
Dr. Leonardo Riella
A kidney transplantation researcher who directs kidney transplantation research at the Mass General Brigham Transplant Center and is overseeing the patient's care.
The details
Falco, a mother of two who has worked as a chef, has been overseen by Dr. Leonardo Riella, director of kidney transplantation research at the Mass General Brigham Transplant Center. The pig kidney has performed the functions of a human kidney, including clearing toxins, making urine and balancing fluids and minerals.
Timeline
Last year: fewer than 26,000 kidney transplants were performed in the United States.
Sunday, November 22, 2026: Falco reached the one-year mark with her pig kidney.
Roadmap
The one-year result extends the research program at the Mass General Brigham Transplant Center, which is studying whether animal organs can address the gap between kidney demand and supply. It adds a long-duration data point to a field that has so far relied on small numbers of experimental cases.
For the roughly 90,000 Americans waiting for a kidney transplant, the result points to a possible future source of organs, though pig kidneys remain experimental and are not yet available as a treatment. Patients on dialysis should continue with current care while such options are still being studied.
The takeaway
Long-term outcomes like this one are the evidence needed before animal-organ transplants can be judged as a viable answer to kidney shortages. Readers following the field should watch for results from additional patients.
Further reading
Explore more biotech developments shaping transplant medicine in the United States.
Source note: This article includes information reported by The New York Times.






